Replies to post #1244 on RedHill Biopharma Ltd (RDHL)

[scottsmith]

Yep -- I did. As I think I posted here, I sold after the BEKINDA results and reading that they would definitely need to do a second phase 3. Given that, and the fact that a stoppage of the 104 trial was highly unlikely, I sold.

I still think 105 and 104 are great candidates. But the company has shown no willingness to partner any drugs for upfront cash. Either that, or no one would make a deal they found reasonable.

I don't know any details about the offering -- except that the last one diluted the company by about 33 percent all told.